Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul B Savage

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Nature Chemical Biology|October 18, 2014
Vaccine development: NKT-cell adjuvants in conjugatePaul B Savage
Annual Review of Immunology|December 8, 2006
The biology of NKT cellsAlbert Bendelac, Paul B Savage, Luc Teyton
Nature Immunology|April 27, 2002
Lipid presentation by CD1: the short and the long lipid storyAlbert Bendelac, Luc Teyton, Paul B Savage
Chemical Society Reviews|August 29, 2006
Glycolipids for natural killer T cellsPaul B Savage, Luc Teyton, Albert Bendelac
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 15, 2010
In vitro amoebicidal activity of a ceragenin, cationic steroid antibiotic-13, against Acanthamoeba castellanii and its cytotoxic potentialZubeyde Akın Polat, Paul B Savage, Carl Genberg
Pathogens (Basel, Switzerland)|September 23, 2022
Effects of Ceragenins and Antimicrobial Peptides on the A549 Cell Line and an In Vitro Co-Culture Model of A549 Cells and <i>Pseudomonas aeruginosa</i>Ozlem Oyardi, Paul B Savage, Cagla Bozkurt Guzel
Diagnostic Microbiology and Infectious Disease|April 23, 2018
Investigation of the in vitro antifungal and antibiofilm activities of ceragenins CSA-8, CSA-13, CSA-44, CSA-131, and CSA-138 against Candida speciesCagla Bozkurt-Guzel, Mayram Hacioglu, Paul B Savage
Journal of Chemotherapy (Florence, Italy)|January 22, 2019
Comparative in vitro antimicrobial activities of CSA-142 and CSA-192, second-generation ceragenins, with CSA-13 against various microorganismsCagla Bozkurt Guzel, Ozlem Oyardi, Paul B Savage
Immunological Reviews|June 21, 2016
The processing and presentation of lipids and glycolipids to the immune systemVincent F Vartabedian, Paul B Savage, Luc Teyton
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 30, 2005
Cationic steroid antibiotics demonstrate DNA delivery propertiesAntoine Kichler, Christian Leborgne, Paul B Savage, et al.
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Nature Chemical Biology|October 18, 2014
Vaccine development: NKT-cell adjuvants in conjugatePaul B Savage
Annual Review of Immunology|December 8, 2006
The biology of NKT cellsAlbert Bendelac, Paul B Savage, Luc Teyton
Nature Immunology|April 27, 2002
Lipid presentation by CD1: the short and the long lipid storyAlbert Bendelac, Luc Teyton, Paul B Savage
Chemical Society Reviews|August 29, 2006
Glycolipids for natural killer T cellsPaul B Savage, Luc Teyton, Albert Bendelac
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 15, 2010
In vitro amoebicidal activity of a ceragenin, cationic steroid antibiotic-13, against Acanthamoeba castellanii and its cytotoxic potentialZubeyde Akın Polat, Paul B Savage, Carl Genberg
Pathogens (Basel, Switzerland)|September 23, 2022
Effects of Ceragenins and Antimicrobial Peptides on the A549 Cell Line and an In Vitro Co-Culture Model of A549 Cells and <i>Pseudomonas aeruginosa</i>Ozlem Oyardi, Paul B Savage, Cagla Bozkurt Guzel
Diagnostic Microbiology and Infectious Disease|April 23, 2018
Investigation of the in vitro antifungal and antibiofilm activities of ceragenins CSA-8, CSA-13, CSA-44, CSA-131, and CSA-138 against Candida speciesCagla Bozkurt-Guzel, Mayram Hacioglu, Paul B Savage
Journal of Chemotherapy (Florence, Italy)|January 22, 2019
Comparative in vitro antimicrobial activities of CSA-142 and CSA-192, second-generation ceragenins, with CSA-13 against various microorganismsCagla Bozkurt Guzel, Ozlem Oyardi, Paul B Savage
Immunological Reviews|June 21, 2016
The processing and presentation of lipids and glycolipids to the immune systemVincent F Vartabedian, Paul B Savage, Luc Teyton
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 30, 2005
Cationic steroid antibiotics demonstrate DNA delivery propertiesAntoine Kichler, Christian Leborgne, Paul B Savage, et al.
Pageof 20